Literature DB >> 4926631

Anencephaly and spina bifida in Israel.

L Naggan.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 4926631

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  12 in total

1.  Possible evidence for secondary degeneration of central nervous system in the pathogenesis of anencephaly and brain dysraphia. A study in young human fetuses.

Authors:  D Ganchrow; A Ornoy
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-10

2.  The sex ratio in spina bifida.

Authors:  W H James
Journal:  J Med Genet       Date:  1979-10       Impact factor: 6.318

3.  The sex ratio in anencephaly.

Authors:  W H James
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

4.  Epidemiology of neural tube defects in Germany.

Authors:  M Koch; W Fuhrmann
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

5.  Shifting genetic patterns in anencephaly and spina bifida.

Authors:  D T Janerich; J Piper
Journal:  J Med Genet       Date:  1978-04       Impact factor: 6.318

6.  Recurrence rates for neural tube defects and vitamin supplementation.

Authors:  W H James
Journal:  J Med Genet       Date:  1981-08       Impact factor: 6.318

7.  Neural tube defects in New South Wales, Australia.

Authors:  B Field
Journal:  J Med Genet       Date:  1978-10       Impact factor: 6.318

8.  Socioeconomic status, neighborhood social conditions, and neural tube defects.

Authors:  C R Wasserman; G M Shaw; S Selvin; J B Gould; S L Syme
Journal:  Am J Public Health       Date:  1998-11       Impact factor: 9.308

9.  Sibs of probands with neural tube defects--a study in the Federal Republic of Germany.

Authors:  M Koch; W Fuhrmann
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

10.  Neural tube malformations: complex segregation analysis and calculation of recurrence risks.

Authors:  J M Lalouel; N E Morton; J Jackson
Journal:  J Med Genet       Date:  1979-02       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.